Advisory Services Network LLC Takes $39000 Position in Anaplan Inc (NYSE:PLAN)

Advisory Services Network LLC purchased a new position in shares of Anaplan Inc (NYSE:PLAN) in the first quarter, according to its most recent …

Anaplan logoAdvisory Services Network LLC purchased a new position in shares of Anaplan Inc (NYSE:PLAN) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 1,000 shares of the company’s stock, valued at approximately $39,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Neuburgh Advisers LLC acquired a new position in Anaplan during the 4th quarter worth approximately $27,000. Advisor Group Inc. purchased a new stake in shares of Anaplan during the 4th quarter worth approximately $41,000. Flinton Capital Management LLC purchased a new stake in shares of Anaplan during the 4th quarter worth approximately $42,000. Legal & General Group Plc purchased a new stake in shares of Anaplan during the 4th quarter worth approximately $74,000. Finally, Close Asset Management Ltd purchased a new stake in shares of Anaplan during the 1st quarter worth approximately $79,000. 35.05% of the stock is owned by institutional investors.

PLAN has been the topic of a number of recent research reports. JMP Securities upped their target price on Anaplan from $40.00 to $50.00 and gave the company an “outperform” rating in a research note on Tuesday, May 28th. SunTrust Banks upped their target price on Anaplan to $52.00 and gave the company a “buy” rating in a research note on Wednesday, May 29th. Zacks Investment Research upgraded Investar from a “hold” rating to a “buy” rating and set a $27.00 price target for the company in a report on Tuesday, June 4th. FBN Securities started coverage on Anaplan in a report on Thursday, April 11th. They issued an “outperform” rating and a $45.00 price target for the company. Finally, Monness Crespi & Hardt boosted their price target on Anaplan from $50.00 to $62.00 and gave the company a “buy” rating in a report on Tuesday, May 28th. Five equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $43.77.

In related news, insider Frank Calderoni sold 149,188 shares of the firm’s stock in a transaction that occurred on Thursday, April 18th. The shares were sold at an average price of $34.79, for a total transaction of $5,190,250.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider David Ying Xian Chung sold 1,763 shares of the firm’s stock in a transaction that occurred on Wednesday, July 3rd. The stock was sold at an average price of $52.41, for a total transaction of $92,398.83. The disclosure for this sale can be found here. Insiders sold 1,487,851 shares of company stock worth $71,001,790 in the last three months. 37.20% of the stock is currently owned by corporate insiders.

NYSE:PLAN opened at $56.83 on Friday. The company has a current ratio of 1.94, a quick ratio of 1.94 and a debt-to-equity ratio of 0.11. Anaplan Inc has a 1-year low of $20.37 and a 1-year high of $57.82. The firm has a 50-day moving average price of $48.27. The stock has a market cap of $7.39 billion and a PE ratio of -33.04.

Anaplan (NYSE:PLAN) last issued its quarterly earnings results on Tuesday, May 28th. The company reported ($0.16) EPS for the quarter, topping the consensus estimate of ($0.34) by $0.18. The company had revenue of $75.80 million for the quarter, compared to the consensus estimate of $70.66 million. The firm’s revenue for the quarter was up 46.9% compared to the same quarter last year. On average, analysts predict that Anaplan Inc will post -1.15 earnings per share for the current year.

About Anaplan

Anaplan, Inc engages in the provision of cloud-based connected planning platform that helps connect organizations and people to make better and faster decisions. It also offers professional services, including consulting, implementation, and training. The company was founded by Michael Gould, John David Guy Haddleton, and Sue Haddleton in 2006 and is headquartered in San Francisco, CA.

Further Reading: How to Use a Moving Average for Trading

Institutional Ownership by Quarter for Anaplan (NYSE:PLAN)

Receive News & Ratings for Anaplan Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Anaplan and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Insider Selling: AtriCure Inc. (NASDAQ:ATRC) SVP Sells 10000 Shares of Stock

Quantum Capital Management increased its stake in shares of AtriCure by 0.7% during the 1st quarter. Quantum Capital Management now owns …

AtriCure logoAtriCure Inc. (NASDAQ:ATRC) SVP Justin J. Noznesky sold 10,000 shares of the stock in a transaction on Monday, June 17th. The shares were sold at an average price of $30.00, for a total value of $300,000.00. Following the completion of the sale, the senior vice president now owns 94,068 shares of the company’s stock, valued at $2,822,040. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

NASDAQ ATRC traded down $0.76 during trading hours on Friday, hitting $31.38. The company’s stock had a trading volume of 151,864 shares, compared to its average volume of 220,718. AtriCure Inc. has a 52 week low of $26.11 and a 52 week high of $36.49. The stock has a market capitalization of $1.23 billion, a P/E ratio of -33.38 and a beta of 0.27. The company has a debt-to-equity ratio of 0.19, a current ratio of 4.37 and a quick ratio of 3.69. The company’s 50-day moving average price is $30.11.

AtriCure (NASDAQ:ATRC) last announced its quarterly earnings results on Thursday, April 25th. The medical device company reported ($0.20) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.24) by $0.04. The business had revenue of $53.97 million for the quarter, compared to analysts’ expectations of $52.45 million. AtriCure had a negative net margin of 7.98% and a negative return on equity of 14.35%. The firm’s revenue for the quarter was up 14.9% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.31) EPS. On average, research analysts anticipate that AtriCure Inc. will post -0.74 EPS for the current fiscal year.

A number of large investors have recently bought and sold shares of the business. Macquarie Group Ltd. increased its stake in AtriCure by 1.0% in the 4th quarter. Macquarie Group Ltd. now owns 65,786 shares of the medical device company’s stock valued at $2,013,000 after buying an additional 681 shares during the last quarter. Quantum Capital Management increased its stake in shares of AtriCure by 0.7% during the 1st quarter. Quantum Capital Management now owns 127,035 shares of the medical device company’s stock worth $3,403,000 after purchasing an additional 845 shares during the last quarter. Bell Rock Capital LLC purchased a new stake in shares of AtriCure during the 1st quarter worth approximately $26,000. Rhumbline Advisers increased its stake in shares of AtriCure by 3.4% during the 1st quarter. Rhumbline Advisers now owns 48,738 shares of the medical device company’s stock worth $1,306,000 after purchasing an additional 1,594 shares during the last quarter. Finally, Legal & General Group Plc increased its stake in shares of AtriCure by 31.0% during the 4th quarter. Legal & General Group Plc now owns 6,958 shares of the medical device company’s stock worth $213,000 after purchasing an additional 1,646 shares during the last quarter. Hedge funds and other institutional investors own 89.28% of the company’s stock.

A number of analysts have commented on ATRC shares. JPMorgan Chase & Co. set a €78.00 ($90.70) price target on shares of Porsche Automobil and gave the company a “neutral” rating in a research report on Friday, April 12th. BTIG Research started coverage on shares of GrubHub in a research report on Tuesday, April 2nd. They set a “buy” rating and a $95.00 price target on the stock. Needham & Company LLC reaffirmed a “buy” rating and set a $120.00 price target (up previously from $115.00) on shares of Synopsys in a research report on Thursday, March 28th. BidaskClub raised shares of Zynerba Pharmaceuticals from a “hold” rating to a “buy” rating in a research report on Thursday, July 4th. Finally, Zacks Investment Research cut shares of Hancock Jaffe Laboratories from a “buy” rating to a “hold” rating in a research report on Wednesday, June 26th. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $36.67.

About AtriCure

AtriCure, Inc develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States and internationally. The company offers Isolator Synergy and Isolator Synergy Access clamps for the treatment of persistent and long-standing persistent atrial fibrillation concomitant to other open-heart surgical procedures; EPi-Sense guided coagulation system used for the coagulation of tissue; and COBRA Fusion surgical ablation system to combine bipolar temperature-controlled radio frequency energy control with monopolar energy.

Further Reading: What is the Beige Book?

Receive News & Ratings for AtriCure Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for AtriCure and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Short Interest in AstroNova Inc (NASDAQ:ALOT) Expands By 23.3%

Boston Partners acquired a new stake in AstroNova during the 4th quarter worth approximately $1,023,000. Quantum Capital Management acquired a …

AstroNova logoAstroNova Inc (NASDAQ:ALOT) saw a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 21,700 shares, a growth of 23.3% from the April 30th total of 17,600 shares. Currently, 0.4% of the shares of the company are sold short. Based on an average daily volume of 37,900 shares, the short-interest ratio is currently 0.6 days.

ALOT has been the subject of a number of analyst reports. ValuEngine raised shares of Zynerba Pharmaceuticals from a “sell” rating to a “hold” rating in a research note on Monday, April 1st. Zacks Investment Research raised shares of Grana y Montero SAA from a “sell” rating to a “hold” rating in a research note on Monday, June 10th.

Several hedge funds have recently modified their holdings of ALOT. Roubaix Capital LLC acquired a new stake in AstroNova during the 1st quarter worth approximately $2,242,000. Boston Partners acquired a new stake in AstroNova during the 4th quarter worth approximately $1,023,000. Quantum Capital Management acquired a new stake in AstroNova during the 4th quarter worth approximately $1,019,000. Punch & Associates Investment Management Inc. lifted its holdings in AstroNova by 7.5% during the 1st quarter. Punch & Associates Investment Management Inc. now owns 414,720 shares of the business services provider’s stock worth $8,456,000 after buying an additional 28,760 shares in the last quarter. Finally, Vanguard Group Inc. lifted its holdings in AstroNova by 8.7% during the 3rd quarter. Vanguard Group Inc. now owns 289,238 shares of the business services provider’s stock worth $6,248,000 after buying an additional 23,155 shares in the last quarter. Hedge funds and other institutional investors own 58.97% of the company’s stock.

Shares of AstroNova stock traded down $0.02 during mid-day trading on Friday, hitting $25.14. The stock had a trading volume of 37,400 shares, compared to its average volume of 35,986. The firm’s 50-day simple moving average is $25.84. AstroNova has a 12-month low of $16.74 and a 12-month high of $27.96. The company has a current ratio of 2.73, a quick ratio of 1.30 and a debt-to-equity ratio of 0.18. The company has a market cap of $180.74 million, a price-to-earnings ratio of 30.66, a P/E/G ratio of 2.39 and a beta of 0.25.

AstroNova (NASDAQ:ALOT) last issued its quarterly earnings data on Wednesday, June 5th. The business services provider reported $0.23 EPS for the quarter, topping the consensus estimate of $0.22 by $0.01. AstroNova had a net margin of 4.68% and a return on equity of 9.75%. The firm had revenue of $36.18 million for the quarter. On average, equities research analysts anticipate that AstroNova will post 0.9 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 24th. Stockholders of record on Monday, June 17th were issued a $0.07 dividend. The ex-dividend date was Friday, June 14th. This represents a $0.28 annualized dividend and a dividend yield of 1.11%. AstroNova’s dividend payout ratio is currently 34.15%.

AstroNova Company Profile

AstroNova, Inc designs, develops, manufactures, and distributes specialty printers, and data acquisition and analysis systems in the United States, Canada, Asia, Europe, Central and South America, and internationally. The company operates through two segments, Product Identification and Test & Measurement (T&M).

Featured Story: Should You Consider an Index Fund?

Receive News & Ratings for AstroNova Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for AstroNova and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Carvana Co. (CVNA), Anaplan (PLAN) Are Circling the Drain: Sell Now

The recent performance of Carvana Co. (NYSE:CVNA) stock in the market spoke loud and clear to investors as CVNA saw more than 1.44M shares in …

The recent performance of Carvana Co. (NYSE:CVNA) stock in the market spoke loud and clear to investors as CVNA saw more than 1.44M shares in trading volumes in the last trading session, way higher than the average trading volume of 1.44M shares by far recorded in the movement of Carvana Co. (CVNA). At the time the stock opened at the value of $67.44, making it a high for the given period, the value of the stock dropped by -4.52%. After the decrease, CVNA touched a low price of $64.02, calling it a day with a closing price of $67.65, which means that the price of CVNA went 64.59 below the opening price on the mentioned day.

Given the most recent momentum in the market in the price movement of CVNA stock, some strong opinions on the matter of investing in the company’s stock started to take shape, which is how analysts are predicting an estimated price of $70.36 for CVNA within consensus. The estimated price would demand a set of gains in total of -34.76%, which goes higher than the most recent closing price, indicating that the stock is in for bullish trends. Other indicators are hinting that the stock could reach an outstanding figure in the market share, which is currently set at 41.82M in the public float and 9.35B US dollars in market capitalization.

Carvana Co. (CVNA) Technical Analysis

When it comes to the technical analysis of CVNA stock, there are more than several important indicators on the company’s success in the market, one of those being the Relative Strength Indicator (RSI), which can show, just as Stochastic measures, what is going on with the value of the stock beneath the data. This value may also indicate that the stock will go sideways rather than up or down, also indicating that the price could stay where it is for quite some time. When it comes to Stochastic reading, CVNA stock are showing 79.16% in results, indicating that the stock is neither overbought or oversold at the moment, providing it with a neutral within Stochastic reading as well.

Additionally, CVNA with the present state of 200 MA appear to be indicating bullish trends within the movement of the stock in the market. While other metrics within the technical analysis are due to provide an outline into the value of CVNA, the general sentiment in the market is inclined toward positive trends.

A Look At Anaplan (NYSE:PLAN)

With the previous 100-day trading volume average of 1.88 million shares, Anaplan (PLAN) recorded a trading volume of 1.62 million shares, as the stock started the trading session at the value of $56.43, in the end touching the price of $57.10 after jumping by 1.19%.

Anaplan (PLAN) Intraday View

PLAN stock seem to be going ahead the lowest price in the last 52 weeks with the latest change of 180.32%.Then price of PLAN also went forward in oppose to its average movements recorded in the previous 20 days. The price volatility of PLAN stock during the period of the last months recorded 3.73%, whilst it changed for the week, now showing 3.05% of volatility in the last seven days. The trading distance for this period is set at 12.00% and is presently away from its moving average by 27.15% in the last 50 days. During the period of the last 5 days, PLAN stock gain around 8.89% of its value, now recording a sink by 65.95%.During the period of the last 12 months, Anaplan (PLAN) jumped by 115.15%.

Consensus Price Target for Anaplan (PLAN)

According to the Reuter’s scale, the company’s consensus rating fall to 2.09 from 2.17, showing an overall improvement during the course of a single month. Based on the latest results, analysts are suggesting that the target price for PLAN stock should be $57.10 per share in the course of the next 12 months. To achieve the target price as suggested by analysts, PLAN should have a spike by 0% in oppose to its present value in the market. Additionally, the current price showcases a discount of 7.9% when compared to the high consensus price target predicted by analysts.

Anaplan (PLAN) Intraday Trading

PLAN shares recorded a trading volume of 1.5 million shares, compared to the volume of 2.46M shares before the last close, presented as its trading average. With the approaching 3.05% during the last seven days, the volatility of PLAN stock remained at 3.73%. During the last trading session, the lost value that PLAN stock recorded was set at the price of $57.10, while the lowest value in the last 52 weeks was set at $20.37. The recovery of the stock in the market has notably added 180.32% of gains since its low value, also recording 21.21% in the period of the last 1 months.

Related Posts:

  • No Related Posts

SuperCom Ltd. (NASDAQ:SPCB) Short Interest Down 5.1% in May

Quantum Capital Management raised its position in SuperCom by 74.4% in the fourth quarter. Quantum Capital Management now owns 72,812 …

SuperCom logoSuperCom Ltd. (NASDAQ:SPCB) saw a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 320,500 shares, a decrease of 5.1% from the April 15th total of 337,900 shares. Based on an average daily volume of 38,200 shares, the days-to-cover ratio is currently 8.4 days. Approximately 2.9% of the company’s stock are sold short.

SPCB traded down $0.02 on Friday, hitting $1.06. 13,941 shares of the company traded hands, compared to its average volume of 16,314. The stock’s 50 day moving average is $1.13. The firm has a market cap of $16.45 million, a PE ratio of 12.22 and a beta of 0.82. SuperCom has a 12-month low of $0.98 and a 12-month high of $2.45.

SuperCom (NASDAQ:SPCB) last issued its earnings results on Monday, June 10th. The industrial products company reported $0.06 earnings per share for the quarter. The firm had revenue of $5.67 million during the quarter. Equities analysts forecast that SuperCom will post 0.15 earnings per share for the current fiscal year.

Several equities research analysts have weighed in on the company. Zacks Investment Research upgraded DLH from a “sell” rating to a “hold” rating in a report on Tuesday. HC Wainwright set a $4.00 price objective on Uranium Energy and gave the stock a “buy” rating in a research report on Tuesday, June 11th. Finally, ValuEngine cut Zosano Pharma from a “buy” rating to a “hold” rating in a research report on Wednesday, May 1st.

A number of institutional investors have recently modified their holdings of SPCB. Ibex Investors LLC purchased a new position in SuperCom in the fourth quarter valued at about $2,745,000. Quantum Capital Management raised its position in SuperCom by 74.4% in the fourth quarter. Quantum Capital Management now owns 72,812 shares of the industrial products company’s stock valued at $100,000 after purchasing an additional 31,053 shares during the period. Lehman & Derafelo Financial Resources LLC purchased a new position in SuperCom in the fourth quarter valued at about $87,000. Finally, Ridgewood Investments LLC raised its position in SuperCom by 54.4% in the first quarter. Ridgewood Investments LLC now owns 20,020 shares of the industrial products company’s stock valued at $28,000 after purchasing an additional 7,050 shares during the period. Hedge funds and other institutional investors own 18.26% of the company’s stock.

SuperCom Company Profile

SuperCom Ltd. provides digital identity, Internet of Things and connectivity, and cyber security products and solutions to governments, and private and public organizations worldwide. The company offers MAGNA, a common platform for ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver’s licenses, and electronic voter registration and election management.

See Also: Trading Ex-Dividend

Receive News & Ratings for SuperCom Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for SuperCom and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts